ANAC News
Archived Headlines
- Anacor Pharmaceuticals slashes estimated IPO price to $5, announces concurrent private placement 11/23/10
- 4 IPOs planned for the week of Nov 22 11/22/10
- 10 IPOs planned for the week of Nov 15 11/15/10
- Anacor Pharmaceuticals discloses terms for $80 million IPO 11/03/10
- Anacor Pharmaceuticals refiles for $86 million IPO 09/10/10
Anacor Pharmaceuticals quiet period ends January 2
Anacor Pharmaceuticals, which is developing treatments for nail fungus and psoriasis using boron-based chemistry, will see its quiet period end on Sunday, January 2. On November 23, the company raised $60 million by offering 12 million shares at $5, below the...read more
US IPO market slows pace in shortened holiday week with four tepid debuts
The US IPO market slowed this week with four small companies raising less than $100 million in their deals and seeing lukewarm receptions from IPO investors. Biotechs Zogenix (ZGNX) and Anacor Pharmaceuticals (ANAC) both slashed the offer prices by roughly ...read more
Chinese real estate agency services provider SYSWIN prices IPO at $7 per ADS; raises $67 million
SYSWIN, a leading provider of real estate agency services to property developers in Beijing, raised $67 million by selling 9.6 million ADSs at $7, well below its originally anticipated terms of 12 million ADSs at a price of $9.25 to $11.25. Earlier on Tuesday, ...read more
Anacor Pharmaceuticals prices upsized IPO at $5, below the original range of $16-$18
Anacor Pharmaceuticals, which is developing treatments for nail fungus and psoriasis using boron-based chemistry, raised $60 million by offering 12 million shares at $5, as outlined in its amendment filed with the SEC earlier today. The biotech had originally...read more